Live
- BJP MP candidate Bharat Prasad visited the student who tried to commit suicide
- PM’s popularity in the fast lane: Autos with 'Har Dil Mein Modi' slogan spotted across Delhi
- Delhi-based political parties are like East India Company: Sukhbir Badal
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
Pandemic is far from over: WHO
The coronavirus pandemic is not even close to being over, said WHO Director-General Tedros Adhanom Ghebreyesus while adding that about 1,80,000 people worldwide have tested positive in the last 24 hours
London: The coronavirus pandemic is not even close to being over, said WHO Director-General Tedros Adhanom Ghebreyesus while adding that about 1,80,000 people worldwide have tested positive in the last 24 hours.
"The reality is this is not close to being over... Globally, the pandemic is actually speeding up," Tedros said.
He said, "For many of our countries to really not hunt down this virus is our failure in contact tracing, because we have lame excuses, saying it's too many and it's too difficult to trace."
Tedros also said that the WHO would be sending a team to Wuhan next week to investigate the potential animal source of the new coronavirus.
Meanwhile, a combination of antiviral drugs commonly used to treat HIV showed no beneficial effects in patients hospitalised with Covid-19 in a large-scale randomised trial, scientists in the UK have found.
The findings "convincingly rule out any meaningful mortality benefit of lopinavir-ritonavir in the hospitalised COVID-19 patients we studied," the scientists running the RECOVERY trial at the University of Oxford said in a statement on Monday.
In March, the RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including lopinavir-ritonavir, an antiviral treatment commonly used to treat HIV.
Over 11,800 patients have been enrolled from 176 NHS hospitals in the UK for the trial.
